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Workstream 2 – led by Dr Jacqueline Stair, with support from Dr Stewart Kirton, Professor Mire Zloh (all UH), with Professor Raffaele 
Giorgetti (Italy)  
 
1. To develop computational approaches which exploit data from both laboratory based and handheld Raman spectroscopy.    
 
2. Computational approaches will be used to estimate or  predict information regarding NPS.  
 
3. This work is linked with Workstreams 1 and 3. 
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• Based on the rapid increase in the number of NPS (EMCDDA, 2013) 
and the continuing high prevalence of drug-related deaths (EU, 2012), 
the European Commission recently awarded funding to a multi-
institutional partnership across five countries led by the University of 
Hertfordshire, UK, to undertake a project looking at NPS. 
 
Background 
• 4 integrated Workstreams 
Methodologies 
Workstream 1 – led by John Corkery; collaborators from UK, Hungary, Italy 
 
This involves collecting a range of information from providers in several countries relating to individuals who have reported using NPSs or died from such use.  
 
Recording of such data allows ascertainment of groups exposed to specific NPSs and their associated harms, helping to formulate improved approaches to identification 
and recording of deaths and ‘near misses’ linked to NPS use.  
 
Data from these reports will inform the choice of compounds to be investigated in WS2 and WS3, and will be disseminated via WS4, with appropriate interpretation and 
guidance, to different stake-holders including those involved in health professionals’ training. 
 
Workstream 3 – led by Dr Colin Davidson, St George’s University of London  (SGUL), with Professor Gaetano Di Chiara (Italy) and 
Professor Emilio Ambrosio (Spain) 
 
1. in vitro neurochemical testing of NPS in rat brain slices, aorta 
 
2. in vivo neurochemical testing in whole rats 
 
3. in vivo behavioural testing in rat models of drug abuse 
 
The most interesting of the NPSs, determined by these in vitro assays, will be examined using in vivo dopamine and 5-HT efflux in the accumbens using microdialysis.  
Long-term effects of selected NPS on rodent cognitive function will be examined as well.  
 
• To monitor, test, profile, and feed back into education and 
prevention knowledge relating to the types of NPS emerging, 
their associated characteristics and potential harms  
 
Aim 
• To develop integrated monitoring and profiling of Novel 
Psychoactive Substances (NPS) in Europe in order to prevent health 
harms and update relevant professionals.  
 
Objective 
EUropean-wide, Monitoring, Analysis and knowledge 
Dissemination on Novel/ Emerging pSychoactiveS   
(EU-MADNESS):  
integrated EU NPS monitoring & profiling to prevent 
health harms and update professionals 
• European Commission – funding awarded of € 635,215. 
• Started 1 April 2014 & lasts 24 months. 
• Principal Investigator – Professor Fabrizio Schifano 
• 12 European Partner Institutions across 5 countries 
The Project 
Workstream 4 – led by Dr Colin Davidson with Mrs Christine Goodair (SGUL), with partners in Scotland (Professor Simon 
Maxwell), Germany (Professor Norbert Scherbaum), Italy (Professor Giovanni Martinotti and Professor 
Raffaele Giorgetti), and Spain  (Professor Magi Farré) 
 
1. Ask healthcare educationalists what they know/teach about NPS 
2. Make new learning resources in multiple languages 
3. Disseminate resources 
4. Get feedback 
 
www.eumadness.eu 
• Reduction in harms and adverse consequences of use, including death, 
through enhanced knowledge on the part of health professionals 
providing interventions, delivering services and treatment. 
• Beneficiaries:  Emergency Services, paramedics, police 
officers/coronial staff, medico-legal professionals, educators, national 
and EU authorities (e.g. National Focal Points, EMCDDA) 
 
Anticipated Benefits 
• Peer-reviewed journal articles 
• Multi-lingual Fact sheets 
• PowerPoint Presentations for 
teaching 
• Website (updated regularly 
and offering membership) 
 
Expected Outputs 
This project is 
funded by the Drug 
Prevention and 
Information 
Programme of the 
European Union  
• Apps; interactive online Q&As 
• Local Scientific/Educational 
meetings poster/Oral 
communications 
• School visits to discuss NPS 
• Seminars/Scientific meetings 
